http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101470282-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_515bc63b9b912e7a8885d57ffdb1e4be
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 2014-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7258da8d0fc85c58ff07ae8029a074e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce4e0af05af09ad3dede3b16cc95aed
publicationDate 2014-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101470282-B1
titleOfInvention Pharmaceutical Composition comprising a combination of a salt and sugar for proventing or treating lax vagina syndrome or colpoxerosis disease and the use thereof
abstract The present invention relates to a pharmaceutical composition for parenteral use for the prevention and treatment of vaginal ataxia or vaginal dryness comprising a combination of salt and a sugar as an active ingredient. The composition of the salt and sugar mixture of the present invention showed strong vasoconstrictive ability as a result of an animal experiment on the vasoconstriction ability of New Zealand white rabbits (New Zealand White), and 100 women in their 20s to 50s Confirming that the composition of the present invention is effective for the treatment and prevention of vaginal ataxia or vaginal dryness by confirming excellent vaginal intensifying action and secretion enhancement effect in one simple clinical example and thus being effective and safe composition for preventing and treating vaginal atrophy or vaginal dryness .
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827267-B2
priorityDate 2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110043448-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1579
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090

Total number of triples: 33.